Vanina de Verneuil, EVP and General Counsel at Vir Biotechnology, Inc. (VIR), sold 14,746 shares at $9.14 ($135K) on 2025-02-26, disclosed to the SEC on 2025-02-27.
Scheduled sale ($135k) by EVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.14 | 7,373 | $67K | 50.0% |
| 2 | $9.14 | 7,373 | $67K | 50.0% |
| Total | $9.14 avg | 14,746 | $135K | 100% |
| Filing → |
| VIR | SELL | 2025-11-07 | $12K | — | Filing → |
| VIR | SELL | 2025-11-04 | $8K | — | Filing → |
| VIR | SELL | 2025-02-25 | $49K | — | Filing → |